Allele rs2010963 C of the VEGFA gene is associated with the decreased risk of primary varicose veins in ethnic Russians

Abstract

Objective

To study the association of polymorphisms rs699947, rs2010963, rs3025039 in the VEGFA gene region and rs1870377, rs2305949, rs2071559 in the VEGFR2 gene region with the risk of primary varicose veins in ethnic Russians.

Methods

Genotypes were determined by real-time PCR allelic discrimination. The case group consisted of 448 patients with primary varicose veins and the control group comprised 609 individuals without a history of chronic venous disease. Association was studied by logistic regression analysis.

Results

Allele rs2010963 C was associated with the decreased risk of varicose veins (additive model of inheritance: odds ratio = 0.73, 95% confidence interval = 0.59–0.91, P = 0.004).

Conclusions

Our results provide evidence that polymorphism rs2010963 located in the 5′ untranslated region of the VEGFA gene can influence genetic susceptibility to primary varicose veins in Russians. Otherwise, it can be in linkage disequilibrium with another functional single nucleotide polymorphism that can alter the level of vascular endothelial growth factor A protein.

Keywords

Varicose veins vascular endothelial growth factor single nucleotide polymorphism association Russians

Get full access to this article

View all access options for this article.

References

Segiet

Brzozowa

Piecuch

et al.

Biomolecular mechanisms in varicose veins development. Ann Vasc Surg 2015; 29: 377–384.

Hollingsworth

Tang

Dialynas

et al.

Varicose veins: loss of release of vascular endothelial growth factor and reduced plasma nitric oxide. Eur J Vasc Endovasc Surg 2001; 22: 551–556.

Ferrara

. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 1999; 77: 527–543.

Y-S

Krilleke

Shima

. VEGF function in vascular pathogenesis. Exp Cell Res 2006; 312: 527–537.

Esser

Wolburg

et al.

Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998; 140: 947–959.

Lim

Kiriakidis

Sandison

et al.

Hypoxia-inducible factor pathway and diseases of the vascular wall. J Vasc Surg 2013; 58: 219–230.

Anwar

Shalhoub

Lim

et al.

The effect of pressure-induced mechanical stretch on vascular wall differential gene expression. J Vasc Res 2012; 49: 463–478.

Kowalewski

Małkowski

Sobolewski

et al.

Vascular endothelial growth factor and its receptors in the varicose vein wall. Acta Angiol 2011; 17: 141–149.

Flórez

De Haro

Bleda

et al.

Analysis of vascular endothelial growth factor gene expression in the tissues of patients with chronic venous insufficiency. Phlebology 2013; 28: 32–37.

10.

Peschen

Grenz

Brand-Saberi

et al.

Increased expression of platelet-derived growth factor receptor alpha and beta and vascular endothelial growth factor in the skin of patients with chronic venous insufficiency. Arch Dermatol Res 1998; 290: 291–297.

11.

Servos

Zachary

Martin

. VEGF modulates NO production: the basis of a cytoprotective effect? Cardiovasc Res 1999; 41: 509–510.

12.

Bouloumié

Schini-Kerth

Busse

. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res 1999; 41: 773–780.

13.

Kim

Moon

Kim

et al.

Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 2001; 276: 7614–7620.

14.

Shoab

Scurr

Coleridge-Smith

. Increased plasma vascular endothelial growth factor among patients with chronic venous disease. J Vasc Surg 1998; 28: 535–540.

15.

Howlader

Coleridge Smith

. Relationship of plasma vascular endothelial growth factor to CEAP clinical stage and symptoms in patients with chronic venous disease. Eur J Vasc Endovasc Surg 2004; 271: 89–93.

16.

Yasim

Kilinc

Aral

et al.

Serum concentration of procoagulant, endothelial and oxidative stress markers in early primary varicose veins. Phlebology 2008; 23: 15–20.

17.

Rogers

D’Amato

. Common polymorphisms in angiogenesis. Cold Spring Harb Perspect Med 2012; 2: a006510–a006510.

18.

Eklöf

Rutherford

Bergan

et al.

Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004; 40: 1248–1252.

19.

Krysa

Jones

van Rij

. Evidence for a genetic role in varicose veins and chronic venous insufficiency. Phlebology 2012; 27: 329–335.

20.

Zhao

Zhang

et al.

Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins. J Vasc Surg 2011; 168: e143–e148.

21.

Surendran

Girijamma

Nair

et al.

Forkhead box C2 promoter variant c.-512C>T is associated with increased susceptibility to chronic venous diseases. PLoS One 2014; 9: e90682–e90682.

22.

Sokolova

Shadrina

Sevost’ianova

et al.

HFE p.C282Y gene variant is associated with varicose veins in Russian population. Clin Exp Med 2016; 16: 463–470.

23.

Jin

Huang

et al.

Analysis of the association between an insertion/deletion polymorphism within the 3’ untranslated region of COL1A2 and chronic venous insufficiency. Ann Vasc Surg 2013; 27: 959–963.

24.

Ban

Shin

C-H

. Vascular endothelial growth factor -634 G/C polymorphism and risk of cancer: an updated meta-analysis. Genet Mol Res 2015; 14: 13906–13914.

25.

Zhou

Luan

Dong

et al.

Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis. Genet Mol Res 2011; 10: 3674–3688.

26.

Zhang

et al.

The association between VEGF +936C/T and -634G/C polymorphisms and breast cancer susceptibility, tumor growth, and metastases: evidence from 20,728 subjects. Cancer Invest 2015; 33: 312–317.

27.

Y-Y

X-Y

Zhan

A-L

et al.

Vascular endothelial growth factor polymorphisms are associated with osteosarcoma susceptibility. Oncotarget 2016; 7: 47711–47719.

28.

Han

Zhang

Xing

et al.

The associations between VEGF gene polymorphisms and diabetic retinopathy susceptibility: a meta-analysis of 11 case-control studies. J Diabetes Res 2014; 2014: 805801–805801.

29.

Sun

Yuan

Cao

et al.

VEGF genetic polymorphisms may contribute to the risk of diabetic nephropathy in patients with diabetes mellitus: a meta-analysis. ScientificWorldJournal 2014; 2014: 624573–624573.

30.

Wang

et al.

Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and meta-analysis of 14 case-control studies. Genet Mol Res 2013; 12: 1035–1044.

31.

et al.

Association of VEGF genetic polymorphisms with recurrent spontaneous abortion risk: a systematic review and meta-analysis. PLoS One 2015; 10: e0123696–e0123696.

32.

Cheng

Hao

Zhou

et al.

Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis. PLoS One 2013; 8: e78173–e78173.

33.

Song

Kim

Lee

. Vascular endothelial growth factor gene polymorphisms and vasculitis susceptibility: a meta-analysis. Hum Immunol 2014; 75: 541–548.

34.

Wei

Chen

Xue

et al.

Polymorphism of VEGF gene in susceptibility to chronic immune-mediated inflammatory diseases: a meta-analysis. Rheumatol Int 2015; 35: 1351–1360.

35.

Lee

Song

. Vascular endothelial growth factor gene polymorphisms and psoriasis susceptibility: a meta-analysis. Genet Mol Res 2015; 14: 14396–14405.

36.

Liu

Zhang

Liu

et al.

Association between VEGF -634G/C polymorphism and osteonecrosis of the femoral head susceptibility: a meta analysis. Int J Clin Exp Med 2015; 8: 10979–10985.

37.

Lambrechts

Storkebaum

Morimoto

et al.

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 2003; 34: 383–394.

38.

Awata

Inoue

Kurihara

et al.

A common polymorphism in the 5’-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002; 51: 1635–1639.

39.

Yang

Andresen

Yang

et al.

Association of vascular endothelial growth factor -634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese. Exp Biol Med 2010; 235: 1204–1211.

40.

Fan

et al.

Association of polymorphisms in the vascular endothelial growth factor gene and its serum levels with diabetic retinopathy in Chinese patients with type 2 diabetes: a cross-sectional study. Chin Med J 2014; 127: 651–657.

41.

Salimi

Yaghmaei

Tabatabaei

et al.

Vascular endothelial growth factor (VEGF)-634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level. J Obstet Gynaecol Res 2015; 41: 1877–1883.

42.

Al-Habboubi

Mahdi

Abu-Hijleh

et al.

The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease. Eur J Haematol 2012; 89: 403–409.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.14 MB